We are live on ! Find out more
ACM

ACT Capital Management Portfolio holdings

AUM $153M
This Fund
S&P 500
This Quarter Est. Return
-12.64%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$94.5M
AUM Growth
-$43.8M
Cap. Flow
-$15M
Cap. Flow %
-15.87%
Top 10 Hldgs %
63.27%
Holding
99
New
7
Increased
9
Reduced
24
Closed
13

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$3.89M
2
DVN icon
Devon Energy
DVN
+$2.41M
3
QTEK
QualTek Services Inc. Class A Common Stock
QTEK
+$2.23M
4
LNTH icon
Lantheus
LNTH
+$1.5M
5
DOCN icon
DigitalOcean
DOCN
+$1.2M

Top Sells

Rank Stock Value
1
ARCT icon
Arcturus Therapeutics
ARCT
+$5.77M
2
UTHR icon
United Therapeutics
UTHR
+$2.92M
3
META icon
Meta Platforms (Facebook)
META
+$2.52M
4
VIR icon
Vir Biotechnology
VIR
+$2.43M
5
AUPH icon
Aurinia Pharmaceuticals
AUPH
+$1.87M

Sector Composition

Rank Sector Weight
1 Healthcare 75.56%
2 Technology 13.28%
3 Energy 4.44%
4 Financials 2.35%
5 Communication Services 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STAA icon
1
STAAR Surgical
STAA
$1.14B
$19M 20.13%
238,100
-20,000
-8% -$1.49M
ARWR icon
2
Arrowhead Research
ARWR
$12.2B
$9.24M 9.78%
201,000
-9,500
-5% -$470K
ARCT icon
3
Arcturus Therapeutics
ARCT
$178M
$6.83M 7.23%
253,300
-226,100
-47% -$5.77M
CLSD
4
DELISTED
Clearside Biomedical
CLSD
$5.63M 5.96%
163,907
-1,660
-1% -$49.7K
NVDA icon
5
NVIDIA
NVDA
$5.31T
$4.23M 4.47%
+155,000
New +$3.89M
KRYS icon
6
Krystal Biotech
KRYS
$9.64B
$3.93M 4.15%
59,000
– –
SSYS icon
7
Stratasys
SSYS
$778M
$3.52M 3.72%
138,500
+45,000
+48% +$1.09M
DVN icon
8
Devon Energy
DVN
$48.5B
$2.63M 2.78%
+44,500
New +$2.41M
NVNO
9
enVVeno Medical
NVNO
$7.39M
$2.56M 2.7%
11,463
+3,963
+53% +$769K
LNTH icon
10
Lantheus
LNTH
$6.61B
$2.21M 2.34%
+40,000
New +$1.5M
EIGR
11
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$2.08M 2.2%
8,333
+3,050
+58% +$482K
IDYA icon
12
IDEAYA Biosciences
IDYA
$3.47B
$1.94M 2.05%
173,500
– –
INMB icon
13
INmune Bio
INMB
$50.5M
$1.94M 2.05%
230,500
– –
IKT icon
14
Inhibikase Therapeutics
IKT
$377M
$1.59M 1.69%
179,417
– –
ADTN icon
15
Adtran
ADTN
$641M
$1.57M 1.66%
85,000
-30,000
-26% -$594K
DOCN icon
16
DigitalOcean
DOCN
$14.6B
$1.45M 1.53%
25,000
+20,500
+456% +$1.2M
AIRS icon
17
AirSculpt Technologies
AIRS
$349M
$1.39M 1.47%
101,500
– –
AFMD
18
DELISTED
Affimed
AFMD
$1.35M 1.43%
30,880
– –
ICAD
19
DELISTED
iCAD Inc
ICAD
$1.31M 1.39%
294,500
-29,600
-9% -$149K
FUBO icon
20
FuboTV Inc
FUBO
$314M
$1.26M 1.33%
16,000
-3,208
-17% -$374K
QTEK
21
DELISTED
QualTek Services Inc. Class A Common Stock
QTEK
$1.14M 1.2%
+354,269
New +$2.23M
MYOV
22
DELISTED
Myovant Sciences Ltd.
MYOV
$1.13M 1.2%
85,000
– –
AWH
23
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$1.04M 1.1%
66,667
– –
ZETA icon
24
Zeta Global
ZETA
$6.75B
$924K 0.98%
72,500
-62,500
-46% -$634K
RRC icon
25
Range Resources
RRC
$8.91B
$911K 0.96%
+30,000
New +$685K
1
2 3 4

Similar funds

BCI
Blue Capital Inc Omaha, Nebraska $153M AUM 28.69% 1-Year Est. Return
APW
Atlantic Private Wealth Chapel Hill, North Carolina $153M AUM 15.75% 1-Year Est. Return
DAM
Doheny Asset Management Los Angeles, California $153M AUM 42.04% 1-Year Est. Return
BVC
Bright Valley Capital Hong Kong $153M AUM 16.24% 1-Year Est. Return
RHAM
Round Hill Asset Management Pasadena, California $153M AUM 6.67% 1-Year Est. Return
RFN
Redwood Financial Network Solon, Ohio $153M AUM 17.17% 1-Year Est. Return
SGM
Sellaronda Global Management New York $152M AUM 2.1% 1-Year Est. Return
HWM
Horizons Wealth Management Asheville, North Carolina $152M AUM 9.43% 1-Year Est. Return

ACT Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, ACT Capital Management held 99 positions worth $94.5M, down 32% from $138M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

ACT Capital Management withdrew a net $15M in Q1 2022, closing 13 positions and reducing 24 holdings. Its most notable exit was United Therapeutics, an estimated $2.92M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, down from 82% a quarter earlier, followed by Technology and Energy.

Against the trend, ACT Capital Management opened a new position in NVIDIA worth $4.23M.

  • ACT Capital Management's largest Q1 2022 buy was NVIDIA: 155,000 shares worth $4.23M.
  • ACT Capital Management added most to DigitalOcean in Q1 2022, an estimated $1.2M increase.
  • ACT Capital Management's biggest Q1 2022 reduction was Arcturus Therapeutics, cutting an estimated $5.77M.
  • ACT Capital Management fully exited United Therapeutics in Q1 2022, selling an estimated $2.92M.
  • ACT Capital Management's ten largest holdings make up 63% of its $94.5M portfolio in Q1 2022.
  • ACT Capital Management opened 7 new positions and closed 13 in Q1 2022.
  • ACT Capital Management's portfolio value fell 32% quarter-over-quarter to $94.5M.

Based on ACT Capital Management's 13F filing for Q1 2022, filed 11 May 2022.